Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplantation (University Hospital Odense)
- Development stage
- Discontinued
- Lead developer
- University Hospital Odense
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Rectal, Oral
01
Overview
Fecal microbiota transplantation (FMT) is an investigational microbiome therapy that was studied by Odense University Hospital for the treatment of psoriatic arthritis. The therapeutic approach involves transferring minimally processed fecal matter from a healthy, screened donor into the recipient's gastrointestinal tract to restore a healthy gut microbial community. The presumed mechanism of action is the modulation of the host's immune system via the restored gut microbiota, which is hypothesized to reduce the systemic inflammation that drives psoriatic arthritis. A Phase 2, double-blind, randomized, placebo-controlled trial (the FLORA trial, NCT03058900) evaluated a single gastroscopic-guided FMT administration into the duodenum as an add-on to methotrexate in patients with active peripheral psoriatic arthritis. [12, 17] While the procedure was found to be safe, it did not demonstrate efficacy over the placebo and was associated with a higher rate of treatment failure. [12, 16, 22]
- Other names
- fecal microbiota transplantFMTfecal bacteriotherapy
Beyond the preview
Go deeper on fecal microbiota transplantation (University Hospital Odense).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplantation (University Hospital Odense).